Literature DB >> 18616565

Behavioural profile of a new mouse model for NPY deficiency.

Tim Karl1, Liesl Duffy, Herbert Herzog.   

Abstract

The abundantly expressed neuropeptide Y (NPY) plays an important role in anxiety and stress reactivity, as exogenous NPY administration reduces anxiety-like behaviour in rodents. However, unlike the potent effects of NPY seen in pharmacological studies, two independent examinations of a genetic mouse model for NPY deficiency have shown only subtle, inconsistent and task-dependent anxiety-related phenotypes for male mutants. Here we present results of a newly developed germline NPY-knockout model, which has been characterized behaviourally using a comprehensive multi-tiered phenotyping strategy. Mice of both sexes were investigated in locomotion and exploration tasks, anxiety-related paradigms, a hippocampus-dependent memory test and a battery of basic tasks screening for sensory and motor functions. Male and female NPY-deficient mice consistently demonstrated suppressed levels of locomotion and exploration. Furthermore, mutant mice exhibited a pronounced anxiogenic-like phenotype when tested in spatiotemporal anxiety-relevant paradigms (i.e. elevated-plus maze, open field and light-dark task). Importantly, this phenotype was more pronounced in male NPY mutants, revealing a moderate sexually dimorphic impact of NPY deficiency on behaviour. Interestingly, lack of NPY did not result in impaired learning and memory in either sex. Our carefully selected comprehensive behavioural phenotyping strategy revealed a consistent hypolocomotive and sex-dependent anxious-like phenotype. This new NPY-knockout mouse model reveals the importance of sex-specific testing. It also offers a potent new model for research into anxiety-related disorders and suggests potential treatment options for these conditions via the NPY system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616565     DOI: 10.1111/j.1460-9568.2008.06306.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  39 in total

1.  Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.

Authors:  S Joshi; I R Tough; H M Cox
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

Authors:  Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz
Journal:  Neuropeptides       Date:  2019-11-07       Impact factor: 3.286

Review 3.  Neuropeptide Y and posttraumatic stress disorder.

Authors:  R Sah; T D Geracioti
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

4.  Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes.

Authors:  Ke Xu; Kwangik Adam Hong; Zhifeng Zhou; Richard L Hauger; David Goldman; Rajita Sinha
Journal:  Psychoneuroendocrinology       Date:  2011-09-13       Impact factor: 4.905

5.  Skeletal phenotype of the neuropeptide Y knockout mouse.

Authors:  Natalie K Y Wee; Benjamin P Sinder; Sanja Novak; Xi Wang; Chris Stoddard; Brya G Matthews; Ivo Kalajzic
Journal:  Neuropeptides       Date:  2018-11-30       Impact factor: 3.286

6.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

7.  Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight.

Authors:  Paul A Baldock; Nicola J Lee; Frank Driessler; Shu Lin; Susan Allison; Bernhard Stehrer; En-Ju D Lin; Lei Zhang; Ronald F Enriquez; Iris P L Wong; Michelle M McDonald; Matthew During; Dominique D Pierroz; Katy Slack; Yan C Shi; Ernie Yulyaningsih; Aygul Aljanova; David G Little; Serge L Ferrari; Amanda Sainsbury; John A Eisman; Herbert Herzog
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

8.  Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.

Authors:  Helen M Cox; Iain R Tough; Anne-Marie Woolston; Lei Zhang; Amy D Nguyen; Amanda Sainsbury; Herbert Herzog
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

9.  Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.

Authors:  David Cheng; Jac Kee Low; Warren Logge; Brett Garner; Tim Karl
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

10.  Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner.

Authors:  Martin E Edelsbrunner; Herbert Herzog; Peter Holzer
Journal:  Behav Brain Res       Date:  2009-05-03       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.